Literature DB >> 30116137

Re: Current treatment options for severe autoimmune hemolytic anemia.

Zeynep Canan Özdemir1,2, Özcan Bör1,2, Ener Çağrı Dinleyici1,2, Eylem Kıral1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30116137      PMCID： PMC6089788          DOI： 10.5152/TurkPediatriArs.2018.2121

Source DB:  PubMed          Journal:  Turk Pediatri Ars


× No keyword cloud information.
  5 in total

1.  New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.

Authors:  Nathalie Aladjidi; Guy Leverger; Thierry Leblanc; Marie Quitterie Picat; Gérard Michel; Yves Bertrand; Brigitte Bader-Meunier; Alain Robert; Brigitte Nelken; Virginie Gandemer; Hélène Savel; Jean Louis Stephan; Fanny Fouyssac; Julien Jeanpetit; Caroline Thomas; Pierre Rohrlich; André Baruchel; Alain Fischer; Geneviève Chêne; Y Perel
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

2.  Autoimmune Hemolytic Anemia in Children: Mayo Clinic Experience.

Authors:  Janani Sankaran; Vilmarie Rodriguez; Eapen K Jacob; Justin D Kreuter; Ronald S Go
Journal:  J Pediatr Hematol Oncol       Date:  2016-04       Impact factor: 1.289

Review 3.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

Authors:  Joseph Schwartz; Anand Padmanabhan; Nicole Aqui; Rasheed A Balogun; Laura Connelly-Smith; Meghan Delaney; Nancy M Dunbar; Volker Witt; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2016-06       Impact factor: 2.821

Review 4.  Autoimmune hemolytic anemia.

Authors:  Bradley C Gehrs; Richard C Friedberg
Journal:  Am J Hematol       Date:  2002-04       Impact factor: 10.047

Review 5.  How I manage cold agglutinin disease.

Authors:  Sigbjørn Berentsen
Journal:  Br J Haematol       Date:  2011-03-08       Impact factor: 6.998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.